<DOC>
	<DOCNO>NCT02244866</DOCNO>
	<brief_summary>To compare efficacy LH supplementation ( Pergoveris ) non-LH supplementation ( Follitropin alpha ) patient age ≥ 35 year undergoing IVF treatment . Study hypothesis : Pergoveris ( LH supplementation ) good follitropin alpha ( non-LH supplementation ) ovarian stimulation age IVF patient .</brief_summary>
	<brief_title>Efficacy Pergoveris Aged IVF Patients</brief_title>
	<detailed_description>A randomize control single center study . Based difference 19.1 % clinical pregnancy rate two treatment group , without LH supplementation , previous study , 90 % power 2-sided P-value 0.05 , number subject require 109 per group ( total 218 ) . The recruitment target 120 subject per group ( total 240 ) allow dropout . Eligible subject randomize block 4 via computer generate random number list either Pergoveris arm follitropin alpha arm . Ovarian stimulation perform use GnRH antagonist protocol . Follitropin alfa ( recombinant FSH ) administer day 2 day 3 menstrual cycle . The first FSH dose determine accord individual patient , base process follow : - AFC ≤ 6 : 300 IU/day - AFC 7-15 : 225 IU/day - AFC ≥ 16 : 150 IU/day GnRH antagonist ( Cetrotide , Merck-Serono ) administer day 5 FSH administration . - Recombinant LH ( form Pergoveris ) supplement day 6 FSH administration . Patients Pergoveris group would administer reduce dose recombinant FSH ( reduce 150 IU/day ) replace Pergoveris ( 150IU FSH + 75IU LH ) /day . - The Follitropin alpha group retain recombinant FSH . In group , number develop follicle inappropriate , dose could titrate depend physician 's judgment . Monitoring follicular development perform vaginal ultrasound probe , quantify LH , estradiol progesterone , start day 5 FSH , base current process hospital . OPU embryo transfer : OPU perform 36 hour hCG administration . Embryos transfer day 2 . Luteal phase support : daily vaginal progesterone Pregnancy test ultrasound : pregnancy test do 14 day embryo transfer . Beta hCG &gt; 5mIU/ml consider positive . Fetal ultrasound perform 3 week positive pregnancy test verify clinical pregnancy .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>age ≥ 35 year body mass index &lt; 28 kg/m2 ≤ 3 previous IVF attempt receive GnRHantagonist protocol agreement participate study , disclose medical event investigator . The subject must willing able comply protocol requirement duration study . give write informed consent understand subject may withdraw consent time participate another interventional clinical trial PCOS WHO group 1 uterine abnormality endocrine disorder hyperprolactinemia , thyroid disorder</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>IVF</keyword>
	<keyword>LH supplementation</keyword>
	<keyword>ovarian stimulation</keyword>
	<keyword>poor responder</keyword>
</DOC>